DrugCards Company

DrugCard provides full-regulatory compliant SaaS to help pharmacovigilance teams, trimming literature screening time by 70% and generating deeper insights about drug safety using sophisticated parsers and AI-tech.

DrugCard, a groundbreaking tool enhances the safety of medicines by using advanced technology to gather critical safety information. Our tool scans over 1000 medical journals in 100 different languages, looking for mentions of drug safety issues like side effects or adverse reactions, and collects this data quickly and accurately.

The core of our innovation is a blend of OCR, parsers, crawlers and AI. These technologies allow us to read and analyze both online and printed medical journals, ensuring we find all mentions of drugs and safety information. This comprehensive approach helps identify potential safety issues that others might miss, contributing to better patient safety.

One of the standout features of our system is its efficiency. Traditional methods of reviewing medical journals are slow and require a lot of manual effort, often taking weeks or months. Our tool performs this task much faster, making the process eight times more efficient. This speed enables pharmaceutical companies to obtain crucial safety information quickly, helping them respond to issues more effectively.

We also provide a high degree of customization for our clients. If a pharmaceutical company needs to monitor specific journals or countries, we can add these to our system within two weeks, significantly faster than the industry standard of six months. This flexibility ensures our clients always have access to the latest and most relevant information.

Technology: Predictive Toxicology and ADMET Modeling
Industry: BioPharma AI
Founded Date: 2021-01-01 00:00:00
Headquarters: Tallinn,Harjumaa,Estonia,Europe
Funding Status: private